Antifibrotic drugs are specialized medications designed to slow down the buildup of excess scar tissue (fibrosis) in organs . they do not cure existing scarring or reverse damage already done, but they help preserve organ function and slow disease progression, most notably in chronic lung conditions.
WHAT ARE NINTIB 30 MG CAPSULES?
NITIB 30 mg is classified as a targeted anti-cancer medication and a Burton’s tyrosine kinase (BTK) Inhibitor . it is a prescription –only oncology drug used to treat specific types of blood cancers and lymphomas .
Key classification:
• Pharmacological class: Bruton’s tryosine kinase (BTK) inhibitor /kinase inhibitor.
• Therapeutic class: Antineoplastic agent/Targeted cancer therapy
• Active ingredient: Ibrutinib
• Prescription status: prescription only medicine.
• Role in slowing the progression of lung fibrosis: NINTIB 30 mg acts as an intracellular-tryrosine kinase inhibitor that slows the progression of lung fibrosis . it targets specific receptors to block proliferation, migration and transformation of lung fibroblast into scar forming mycofibroblast , thereby reducing functional lung decline.
WHAT ARE THE MEDICAL USES OF NITIB 30 CAPSULES?
Medical uses of NINTIB 30 capsules are:
A) IDIOPATHIC PLUMONARY FIBROSIS (IPF)
NINTIB 30 mg is a tyrosine kinase inhibitor prescribed to slow the decline of lung function and reduce disease progression in idiopathic fibrosis (IPF). It is essential to follow the dosage prescribed by a physician as an appropriate strength is tailored to the individual .
• Slows Disease progression
NINTIB 30 mg capsule contain nintedanib, an antifibroitic medication that inhibits tyrosine kinase to block cellular signaling pathways responsible for lung tissue scarring. While it does not reverse existing lung damage, it significantly reduces the rate of decline in forced vital capacity and slows the progression of chronic fibrosing interstinal lung diseases.
• Helps preserve lung function
NINTIB 30 mg helps preserve lung function by slowing down the progression of scarring and tissue thickening in chronic fibrosing lung diseases like idiopathic pulmonary fibrosis. It lowers the yearly rate at which a patients breathing and forced vital capacity drops. It does not cure the underlying damage but it helps stabilize respiratory capacity for long-term management.
B) PROGRESSIVE PLUMONARY FIBROSIS (PPF)
NINTIB 30 mg is a tyrosine kinase inhibitor approved for the treatment of progressive pulmonary fibrosis (PPF). This medication is used to slow the progression of scarring in the lungs, although it cannot reverse existing damage. It acts on pathways involved in blood vessel formation and tissue remolding.
• Management of chronic fibrosing interstitial lung diseases
NINTIB 30 mg is used to treat chronic fibrosing interstitial lung disease (ILDS) with a progressive phenotype. It blocks multiple receptor tyrosine kinase inhibitor to reduce fibroblast proliferation and lung scarring. It also treats idiopathic pulmonary fibrosis (IPF) , systematic sclerosis –associated ILD, and progressive fibrosing ILD.
• Reduces the rate of lung function decline
NINTIB 30 mg reduces the rate of lung function decline in patients with conditions like idiopathic pulmonary fibrosis and chronic fibrosing interstitial lung diseases. It blocks the specific enzymes that trigger cell growth and scarring in lung tissues. It helps patients maintain breathing capacity longer, though it is not a cure.
C) SYSTEMATIC SCELOROSIS –ASSOCIATED INTERSTINAL LLUNG DISEASE (SSC-ILD)
NINTIB 3O mg is an oral kinase inhibitor that slows the progression of systematic sclerosis associated interstitial lung disease by reducing the annual rate of decline in forced vital capacity (FCV). It is frequently evaluated and used alongside background such as mycophenolate mofetil.
• Helps slow lung fibrosis
NINTIB 30 mg helps slow lung fibrosis by acting as a tyrosine kinase inhibitor . it blocks multi-receptor enzymes that signal tissue scarring and cell proliferation. It also slows down the accumulation of scar tissue and the decline of respiratory capacity.
• Supports respiratory function
NINTIB 30 capsules is an oral anti-fibrotic medication that helps preserves respiratory capacity . it works by blocking specific enzyme that cause scarring and stiffening in the lungs, which slows down the decline of lung function in chronic fibrosing conditions.
HOW NITIB 30 CAPSULES WORK?
NINTIB 30 works as an tyrosine kinase inhibitor . it blocks specific cell enzyme and growth factors that cause inflammation , blood vessel formation in tumors, and tissue scaring in the lungs ,helping to slow down lung function decline, or cancer progression. It works by the following ways:
• Mechanism of action of NINTEDANIB
NINTEDANIB is a small molecule ,multi-targeted tyrosine kinase inhibitor that blocks intracellular signaling pathways driven by key growth factors receptor. It reduces fibroblast proliferation ,migration and transformation slowing progressive lung scarring.
• Inhibits multiple tyrosine kinase receptors involved in fibrosis
NINTIB is a small-molecule multiple tyrosine kinase inhibitor that blocks key growth factor receptor implicated in the pathogenesis of fibrosis. By competively binding to the ATP –binding pockets of these receptors, it inhibits intracellular signaling cascades responsible for the fibroblast proliferation, migration and differention .
• Reduces fibroblast activity and scar tissue formation
NINTIB 30 mg , a tyrosine kinase inhibitor blocks specific growth factor receptors driving fibroblast proliferation and collagen production. By inhibiting these cellular pathways, it reduces fibroblast activation and slows the buildup of internal scar tissue.
• Helps slows disease progression
NINTIB 30 mg is an oral anti-fibrotic medication that inhibits tyrosine kinase to slow lung scarring and decreases the rate of lung function decline in conditions like idiopathic pulmonary fibrosis . it lowers the decline rate of forced vital capacity (FVC) to help maintain breathing capacity .
CONCLUSION
NINTIB 30 mg is effective at slowing the rate of lung function decline in patients with idiopathic pulmonary fibrosis and other progressive interstitial lung diseases. While not a cure, it manages disease progression and improves long-term outcomes , though it requires monitoring for side effects like diarrhea and liver enzyme elevation.
FREQUENTLY ASKED QUESTIONS (FAQs):
QUESTION:WHAT ARE NINTIB 30 CAPSULES USED FOR?
NINTIB 30 mg capsules is used to treat idiopathic pulmonary fibrosis (IPF), Chronic fibrosing interstitial lung diseases with a progressive phenotype, systematic sceloris-associated interstitial lung diseases .
QUESTION: HOW DOES NINTEDANIB WORK?
NINTENIB is a targeted oral medication that act as a tyrosine kinase inhibitor which slows down buildup of scar tissue in the lungs by blocking specific chemical signals and enzymes that trigger cell growth , blood vessel formation and tissue stiffning.
QUESTION: CAN NITIB CURE PLUMONARY FIBROSIS ?
No, NINTIB does not cure pulmonary fibrosis . in fact, it is an anti-fibrotic medication specifically used to treat pulmonary fibrosis and slow down the buildup of scar tissue in the lungs.
REFRENCES:
1)https://www.macariushealth.com/products/oncology-cancer-care/nitib-140mg-capsule-140mg/
2https://www.truemeds.in/medicine/nitib-140-mg-capsule-30-tm-cacr1-010506
